Navigation Links
SGX Pharmaceuticals Announces Financial Results for the Three and Nine Months Ended September 30, 2007
Date:11/13/2007

. More information on the pipeline and drug discovery platform can be found at http://www.sgxpharma.com and in the Company's various filings with the Securities and Exchange Commission.

Forward-looking Statements

Statements in this press release that are not strictly historical in nature are forward-looking statements. These statements include, but are not limited to, statements related to research and development programs, plans for 2007 and 2008, expectations regarding the timing of the filing of INDs and commencement of IND enabling activities and preclinical and clinical studies, partnership opportunities, the potential of the Company's inhibitors as treatments for certain cancers, partnering opportunities for the Company's research and development programs and the ability to discover, develop and commercialize cancer therapeutics. These statements are only predictions based on current information and expectations and involve a number of risks and uncertainties. Actual events or results may differ materially from those projected in any of such statements due to various factors, including the risks and uncertainties inherent in drug discovery, development and commercialization, which include, without limitation, the potential failure of development candidates to advance through preclinical studies or demonstrate safety and efficacy in clinical testing and the ability to file INDs or commence IND enabling activities or preclinical or clinical studies in the referenced time frames. The results of early preclinical studies or clinical trials may not be predictive of future results, and the Company cannot provide any assurances that any of its compounds or development candidates will have favorable results in preclinical studies or future clinical trials. In addition, results may be affected by risks related to the implementation of its collaborations, the failure to successfully complete collaborations
'/>"/>

SOURCE SGX Pharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... , ... July 29, 2015 , ... July is National UV Awareness Month, and in ... DC shares tips on how to protect skin from the sun, as well as how ... cancer, and is one of the most common skin conditions in America. Many people do ...
(Date:7/29/2015)... ... , ... A June 10, 2015 article from the News-Press, entitled " It's ... having regular skin cancer screenings from an early age. Skin cancer can strike at ... early, skin cancer is rarely fatal; however, if left alone for too long, the ...
(Date:7/29/2015)... ... 29, 2015 , ... Employee Fiduciary, LLC announces the launch of its new, ... types of plans administered, years in business, and credentials of all Employee Fiduciary financial ... plan with Employee Fiduciary. A search can be done by zip code so a ...
(Date:7/29/2015)... ... July 29, 2015 , ... Several years ago, in order to ... autism, Little City took a proactive stance and began planning the Children’s Village consisting ... provides valuable support to building the third home. , “We are very pleased to ...
(Date:7/29/2015)... ... , ... Attorneys representing American families in national talcum powder lawsuits announce the ... a page dedicated to news related to pending talcum powder lawsuits, as well as ... News page was launched with eight initial articles. , “We decided to add ...
Breaking Medicine News(10 mins):Health News:July is UV Awareness Month: Learn Top Tips from a Prominent Dermatologist this National UV Awareness Month 2Health News:July is UV Awareness Month: Learn Top Tips from a Prominent Dermatologist this National UV Awareness Month 3Health News:Get Checked for Skin Cancer Early and Often 2Health News:Get Checked for Skin Cancer Early and Often 3Health News:Employee Fiduciary Launches Financial Advisor Directory 2Health News:Little City Receives $500,000 Matching Grant from The Coleman Foundation 2Health News:Little City Receives $500,000 Matching Grant from The Coleman Foundation 3Health News:National Attorneys Provide Regular Talcum Powder Lawsuit News Updates 2Health News:National Attorneys Provide Regular Talcum Powder Lawsuit News Updates 3
... the number of influenza cases over the last four months ... statistics released by the Public// Health Agency on Dec 16. ... March or early April and the Calgary Health Region monitors ... A are; sudden headaches and fever, dry coughs and aching ...
... Ruth A. Kleinerman and his colleagues quantifies the risk ... tissue sarcomas and finds that// this risk persists for ... ,The findings published in the January 3 issue of ... importance of regular medical surveillance for these patients, the ...
... on ailments related to stomach like diarrhoea, food poisoning ... NHS Direct this festive season. NHS Direct is// a ... contacted on 0845 46 47. ,Stomach ache, ... calls received during the festive period. ,NHS ...
... U.S. Centers for Disease Control and Prevention (CDC) shows that ... ,The CDC defines binge drinking as "a common ... Alcohol Abuse and Alcoholism defines binge drinking as a pattern ... at least 0.08 percent. ,Binge drinking is now ...
... a busy man today; fielding complaints from the public, a ... taken to court, from an NGO.// ,The yoga ... hold the key to curing AIDS by performing yoga and ... earlier rubbished these statements, saying while he supported the practice ...
... A British doctor of Indian origin and his colleague are ... a challenge to the monopoly of multinational drug companies. ... and Steve Brocchini from the London School of Pharmacy are ... C. ,The two academics have devised a way ...
Cached Medicine News:Health News:Risk Of Soft Tissue Sarcomas In Hereditary Retinoblastoma Survivors 2Health News:Risk Of Soft Tissue Sarcomas In Hereditary Retinoblastoma Survivors 3Health News:NRI Doctor's R&D Model in India to Slash Cost of Drugs 2
(Date:7/28/2015)... JOLLA, Calif. , July 28, 2015   ... biopharmaceutical company leading the discovery and development of innovative ... financial results and highlights for the quarter ended June ... U.S. financial markets close. Regulus will ... 4, 2015, at 5:00 pm Eastern Daylight Time to ...
(Date:7/28/2015)... 2015 On the afternoon of August 11, ... CPI International, Inc. (CPI), plans to file its Form ... with the Securities and Exchange Commission and to issue ...  At 11 a.m. (EDT) on Wednesday, August 12, 2015, ... with this release that will be Web cast simultaneously ...
(Date:7/28/2015)... 2015 A German Diabetes Center clinical study ... probiotic enriches human gut microbiota and modifies gut ... study involved daily administration of Nutraceutix,s L. reuteri ... patented BIO- tract ® delivery technology that ... their way to the intestinal tract. The ...
Breaking Medicine Technology:Regulus Announces Timing for Second Quarter 2015 Financial Results Webcast and Conference Call 2Regulus Announces Timing for Second Quarter 2015 Financial Results Webcast and Conference Call 3CPI International To Announce Third Quarter 2015 Financial Results 2Nutraceutix's L. reuteri Probiotic Clinically Proven to Modulate Gut Insulin Metabolism 2
... International Myeloma Workshop held in,Kos, Greece ... with bortezomib, dexamethasone and lenalidomide plus,dexamethasone, ... as a single agent in patients ... 29, 2007 /PRNewswire-FirstCall/ -- Keryx,Biopharmaceuticals, Inc. ...
... 2007--A cervical cancer vaccine has shown 90%,efficacy for prevention ... papillomavirus (HPV) types targeted by,the vaccine, conclude authors of ... of The Lancet., HPV types 16 and 18 account ... there are up to 15,oncogenic HPV types which can ...
Cached Medicine Technology:Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 2Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 3Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 4Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 5Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 6Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 7Vaccine Can Prevent Cervical Cancer and Precancerous Lesions 2
... 3000 Plus Sectioning System provides a versatile ... or plant tissues. The 3000 employs ... without freezing or embedding. The creation ... destruction of enzyme activities, and other deleterious ...
... Vibratome comes standard with a square ... blocks are utilized for mounting specimens ... vice. The blocks are annodized ... can be reused. They are ...
Injector blades come ten to an injector and allow for the easy replacement of Vibratome cutting blades....
... Works includes everything from the care ... fuse, Spare Fluorescent Bulb, additional Vibratome ... Blocks, and a Specimen Tray. ... stage, 1/2" speciment mounts, replacement rotating ...
Medicine Products: